I am a clinician and clinical investigator with particular interest in lymphoma, including both B-cell and T-cell lymphomas. My priority is to deliver the best possible care to patients and increase access to clinical trials and state of the art therapies. In my research pursuits, I hope to help develop novel immune-based therapies for lymphoma that harness the immune system to achieve durable remissions with decreased toxicity.
I am interested in immune-based therapies for lymphoma, including transplant, chimeric antigen receptor (CAR) T-cell therapy, and checkpoint blockade. I have a particular interest in immunotherapy and targeted therapy for cutaneous T-cell lymphomas.
